Rifapentine is an antibacterial prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of active tuberculosis (TB). (Active TB is also called TB disease.) Rifapentine is also FDA-approved for the treatment of latent TB infection to prevent the infection from advancing to active TB disease. TB can be an opportunistic infection (OI) of HIV. Its therapeutic use is listed as anti-infectives, antibiotics and antituberculars. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Priftin, Cyclopentylrifampicin and Rifapentinum. Its PubChem CID is 135403821.
Rifapentine
| CAS No | 61379-65-5 |
|---|---|
| Molecular Formula | C47H64N4O12 |
| Molecular Weight | 877.0 g/mol |
| Synonyms | [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
S. Food and Drug Administration (FDA) for the treatment of active tuberculosis (TB). ) Rifapentine is also FDA-approved for the treatment of latent TB infection to prevent the infection from advancing to active TB disease.
The listed CAS number is 61379-65-5.
The listed molecular formula is C47H64N4O12.
The listed molecular weight is 877.0 g/mol.
[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate.
The source lists Priftin, Cyclopentylrifampicin and Rifapentinum.